Yang M, Zhang D, Yuan Z, Chen D, Ju H, Wu B
NPJ Precis Oncol. 2025; 9(1):75.
PMID: 40089605
DOI: 10.1038/s41698-025-00864-2.
Garcia-Simon N, Valentin F, Romero A
Clin Transl Oncol. 2025; .
PMID: 39794684
DOI: 10.1007/s12094-024-03825-6.
Shaz H, Nandi P, Sengupta S
Arch Microbiol. 2024; 207(1):14.
PMID: 39690285
DOI: 10.1007/s00203-024-04214-x.
Orzuna-Orzuna J, Lara-Bueno A, Gloria-Trujillo A, Mendoza-Martinez G, Miranda-Romero L, Hernandez-Garcia P
Vet Sci. 2024; 11(11).
PMID: 39591294
PMC: 11599106.
DOI: 10.3390/vetsci11110520.
Requesens M, Foijer F, Nijman H, de Bruyn M
Front Immunol. 2024; 15:1462496.
PMID: 39544936
PMC: 11562473.
DOI: 10.3389/fimmu.2024.1462496.
Founder pathogenic variants in colorectal neoplasia susceptibility genes in Ashkenazi Jews undergoing colonoscopy.
Matis T, Domecq C, Hamel N, Castellsague E, Lopez-Doriga A, Marotta S
BJC Rep. 2024; 2(1):17.
PMID: 39516274
PMC: 11523938.
DOI: 10.1038/s44276-024-00045-x.
Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis.
La Vecchia M, Sala G, Sculco M, Aspesi A, Dianzani I
Clin Exp Med. 2024; 24(1):248.
PMID: 39470880
PMC: 11522171.
DOI: 10.1007/s10238-024-01505-x.
A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation.
Jin Y, Huang R, Guan W, Wang Z, Mai Z, Li Y
Signal Transduct Target Ther. 2024; 9(1):227.
PMID: 39218995
PMC: 11366758.
DOI: 10.1038/s41392-024-01939-5.
In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer Syndromes.
Fasano C, Lepore Signorile M, De Marco K, Forte G, Disciglio V, Sanese P
Cells. 2024; 13(16.
PMID: 39195204
PMC: 11352798.
DOI: 10.3390/cells13161314.
Cancer, metastasis, and the epigenome.
Kiri S, Ryba T
Mol Cancer. 2024; 23(1):154.
PMID: 39095874
PMC: 11295362.
DOI: 10.1186/s12943-024-02069-w.
CSCO guidelines for colorectal cancer version 2024: Updates and discussions.
Chen L, Hu H, Yuan Y, Weng S
Chin J Cancer Res. 2024; 36(3):233-239.
PMID: 38988483
PMC: 11230882.
DOI: 10.21147/j.issn.1000-9604.2024.03.01.
Predictive modeling for the germline pathogenic variant of the APC gene in patients with adenomatous polyposis: proposing a new APC score.
Takao M, Yamaguchi T, Eguchi H, Suzuki O, Mori Y, Chika N
Surg Today. 2024; 55(2):229-237.
PMID: 38970662
DOI: 10.1007/s00595-024-02894-y.
Attenuated adenomatous polyposis with MSH6 variation: Two case reports.
Ha G, Lee M, Ahn A, Chung M, Kim K
Medicine (Baltimore). 2024; 103(27):e38791.
PMID: 38968511
PMC: 11224831.
DOI: 10.1097/MD.0000000000038791.
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants.
Gallon R, Brekelmans C, Martin M, Bours V, Schamschula E, Amberger A
NPJ Precis Oncol. 2024; 8(1):119.
PMID: 38789506
PMC: 11126593.
DOI: 10.1038/s41698-024-00603-z.
Mutational signatures of colorectal cancers according to distinct computational workflows.
Battuello P, Corti G, Bartolini A, Lorenzato A, Sogari A, Russo M
Brief Bioinform. 2024; 25(4).
PMID: 38783705
PMC: 11116831.
DOI: 10.1093/bib/bbae249.
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint....
Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, Maffioli A, Bisseling T
Br J Surg. 2024; 111(5).
PMID: 38722804
PMC: 11081080.
DOI: 10.1093/bjs/znae070.
Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells.
Andrianova M, Seplyarskiy V, Terradas M, Sanchez-Heras A, Mur P, Soto J
Eur J Hum Genet. 2024; 32(7):837-845.
PMID: 38658779
PMC: 11219999.
DOI: 10.1038/s41431-024-01598-8.
Curative resection via right hemicolectomy and regional lymph node dissection for colonic adenomatous polyposis of unknown etiology with adenocarcinomas localized in the right side of the colon: a case report.
Aoyama S, Inoue A, Kagawa Y, Komori T, Ozato Y, Nishizawa Y
Surg Case Rep. 2024; 10(1):93.
PMID: 38647838
PMC: 11035501.
DOI: 10.1186/s40792-024-01890-1.
The Natural History of Hereditary Colorectal Cancer Syndromes: From Phenotype to Genotype? Where Do We Stand and What Does the Future Hold?.
Church J
Clin Colon Rectal Surg. 2024; 37(3):127-132.
PMID: 38606050
PMC: 11006442.
DOI: 10.1055/s-0043-1770380.
Heterogeneous expression of ARID1A in colorectal cancer indicates distinguish immune landscape and efficacy of immunotherapy.
Guan X, Cui L, Ruan Y, Fang L, Dang T, Zhang Y
Discov Oncol. 2024; 15(1):92.
PMID: 38555560
PMC: 10982246.
DOI: 10.1007/s12672-024-00955-9.